Jin Medical International Ltd. (ZJYL)

Jin Medical International Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	9.08	7.46	8.14	6.93	4.79	3.67
Short-Term Investments	21.02	22.17	18.62	9.77	2.28	2.05
Cash & Short-Term Investments	30.1	29.63	26.76	16.7	7.07	5.73
Cash Growth	-2.75%	10.74%	60.24%	136.23%	23.43%	101.69%
Accounts Receivable	5.51	5.91	8.46	4.23	4.08	4.86
Other Receivables	1.13	0.89	0.32	0.08	0.17	1.11
Receivables	6.65	6.8	8.78	4.31	4.25	5.98
Inventory	6.48	6.95	7.12	5.86	6.88	7.04
Prepaid Expenses	0.08	0.15	0.17	0.06	-	-
Other Current Assets	1.25	0.61	-	4.19	0.7	0.67
Total Current Assets	44.56	44.14	42.82	31.12	18.9	19.42
Property, Plant & Equipment	9.9	7.98	1.72	1.48	1.63	2.11
Other Intangible Assets	1.12	1.1	1.15	0.15	0.16	0.19
Long-Term Deferred Tax Assets	0.24	0.14	0.12	0.15	0.25	0.18
Other Long-Term Assets	0.01	-	-	-	-	-
Total Assets	55.84	53.37	45.8	32.9	20.94	21.9

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	2.6	3.26	3.01	3.39	4.11	5.35
Accrued Expenses	0.45	0.47	0.68	0.33	0.47	0.74
Short-Term Debt	17.98	18.84	11.32	4.11	-	-
Current Portion of Leases	0.06	0.07	0.19	-	-	-
Current Income Taxes Payable	0.23	0.26	0.81	0.26	0.17	0.1
Current Unearned Revenue	0.64	0.61	0.8	0.83	0.83	1.68
Other Current Liabilities	0.87	0.28	0.34	0	0.12	0.01
Total Current Liabilities	22.82	23.8	17.15	8.92	5.7	7.87
Long-Term Leases	-	-	0.1	-	-	-
Total Liabilities	25.69	23.8	17.25	8.92	5.7	7.87

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	6.75	6.75	6.75	6.44	0.08	0.08
Retained Earnings	23.7	23.81	22.61	18.94	16.06	13.35
Comprehensive Income & Other	-0.14	-0.92	-0.56	-1.4	-0.91	0.59
Total Common Equity	30.32	29.64	28.82	23.98	15.24	14.03
Minority Interest	-0.17	-0.07	-0.26	-	-	-
Shareholders' Equity	30.15	29.57	28.55	23.98	15.24	14.03
Total Liabilities & Equity	55.84	53.37	45.8	32.9	20.94	21.9

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	20.9	18.91	11.6	4.11	-	-
Net Cash (Debt)	9.2	10.72	15.15	12.59	7.07	5.73
Net Cash Growth	-38.83%	-29.26%	20.41%	78.04%	23.43%	2879.90%
Net Cash Per Share	1.18	1.37	1.94	1.73	1.05	0.85
Filing Date Shares Outstanding	78.43	7.83	7.83	7.83	6.75	20
Total Common Shares Outstanding	7.83	7.83	7.83	7.8	6.75	20
Working Capital	21.73	20.35	25.66	22.19	13.2	11.55
Book Value Per Share	3.87	3.79	3.68	3.08	2.26	0.70
Tangible Book Value	29.2	28.54	27.67	23.82	15.07	13.84
Tangible Book Value Per Share	3.73	3.65	3.53	3.06	2.23	0.69
Buildings	2.53	2.45	2.49	2.4	2.46	2.71
Machinery	2.95	2.84	2.74	2.56	2.54	2.76
Construction In Progress	8.54	6.54	-	-	-	-
Leasehold Improvements	0.3	0.29	0.36	0.28	0.29	0.32

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 5, 2026

Data Sources Report a data error